Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Douglas Maya Miles

Plan Propio-Acceso
dmaya-ibis@us.es
Área de conocimiento: Fisiología
Departamento: Fisiología
Grupo: Enfermedades hepáticas y digestivas - CTS-1106 (Universidad de Sevilla)

Investiga en

Palabras clave
Líneas de investigación
Resumen
Tipo Año Título Fuente
Resumen congreso2025 FICE-4C nomogram can help anticipating liver related complications in non-cirrhotic MASLD patients JOURNAL OF HEPATOLOGY
Resumen congreso2025 Impact of anthropometric and body composition on response to lifestyle intervention in patients living with MASLD JOURNAL OF HEPATOLOGY
Artículo2025 Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis JHEP Reports
Resumen congreso2025 Patients with chronic liver disease present elevated plasma levels of peptidylprolyl isomerase C associated with the degree of fibrosis JOURNAL OF HEPATOLOGY
Resumen congreso2025 Platelet-derived extracellular vesicles (PEVs) in hepatocellular carcinoma. Emerging diagnostic biomarkers JOURNAL OF HEPATOLOGY
Artículo2025 Regulation of transcription elongation anticipates alternative gene expression strategies across the cell cycle PLOS ONE
Artículo2025 Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension Biology of Sex Differences
Resumen congreso2025 Systematic review of care pathways for metabolic dysfunction-associated steatotic liver disease (MASLD) JOURNAL OF HEPATOLOGY
Resumen congreso2025 The role of extracellular ATP (ATPe) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) JOURNAL OF HEPATOLOGY
Resumen congreso2024 A NOVEL SERUM DIAGNOSTIC SIGNATURE FOR LIVER FIBROSIS AND "AT RISK" MASH VALIDATED IN A POPULATION-SCALE SCREENING HEPATOLOGY
Artículo2024 Biomarcadores en MASLD, ¿estamos ante una nueva era? GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2024 Differential transcriptomic profile in platelet-derived extracellular vesicles in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) JOURNAL OF HEPATOLOGY
Resumen congreso2024 Dysregulation of ureagenesis and glutaminolysis in DIAMONDTM mice played a major role in MASLD progression JOURNAL OF HEPATOLOGY
Resumen congreso2024 ENTPD1/ CD39 REGULATES INFLAMMATORY PROCESS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD) HEPATOLOGY
Artículo2024 Fibroblast growth factor 21 is a hepatokine involved in MASLD progression UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
Resumen congreso2024 Identification and assessment of new circulating serological biomarkers for the evaluation of liver disease severity in MASLD patients JOURNAL OF HEPATOLOGY
Revisión2024 Novel insights into metabolic-associated steatotic liver disease preclinical models LIVER INTERNATIONAL
Resumen congreso2024 Platelet-derived extracellular vesicles (PEVs) as a potential biomarker for hepatocellular carcinoma (HCC) JOURNAL OF HEPATOLOGY
Short Survey2024 Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2024 The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis Journal of Gastroenterology
Letter2023 A second update on mapping the human genetic architecture of COVID-19 NATURE
Resumen congreso2023 Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD) JOURNAL OF HEPATOLOGY
Resumen congreso2023 Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2023 Identification of new serological biomarkers for the detection of significant fibrosis HEPATOLOGY
Artículo2023 Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis CELL DEATH & DISEASE
Artículo2023 Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. LIVER INTERNATIONAL
Resumen congreso2023 Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH JOURNAL OF HEPATOLOGY
Artículo2023 Transcription and FACT facilitate the restoration of replication-coupled chromatin assembly defects Scientific reports
Artículo2022 A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy CANCERS
Revisión2022 Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver Frontiers in Endocrinology
Artículo2022 Detailed stratified GWAS analysis for severe COVID-19 in four European populations. HUMAN MOLECULAR GENETICS
Resumen congreso2022 Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model JOURNAL OF HEPATOLOGY
Resumen congreso2022 Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Artículo2022 Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation Scientific reports
Artículo2022 Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma LIVER INTERNATIONAL
Artículo2022 Novel genes and sex differences in COVID-19 severity. HUMAN MOLECULAR GENETICS
Artículo2022 Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD Journal of Gastroenterology
Artículo2021 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. JOURNAL OF CLINICAL INVESTIGATION
Revisión2021 Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases FRONTIERS IN IMMUNOLOGY
Resumen congreso2021 Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients JOURNAL OF HEPATOLOGY
Artículo2021 Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis Revista Española de Enfermedades Digestivas
Artículo2021 Implementing personalized medicine in COVID-19 in Andalusia: an opportunity to transform the healthcare system. Journal of personalized medicine
Artículo2021 Management of NAFLD patients with advanced fibrosis LIVER INTERNATIONAL
Artículo2021 Mapping the human genetic architecture of COVID-19. NATURE
Resumen congreso2020 Circulating PCSK9 levels correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2020 Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study Clinical and translational gastroenterology
Resumen congreso2020 Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis JOURNAL OF HEPATOLOGY
Resumen congreso2020 LncRNA-H19 as a marker of liver progression from steatosis to hepatocellular carcinoma JOURNAL OF HEPATOLOGY
Artículo2019 Crosstalk between chromatin structure, cohesin activity and transcription Epigenetics & Chromatin
Resumen congreso2019 Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study JOURNAL OF HEPATOLOGY
Revisión2019 Histone stress: an unexplored source of chromosomal instability in cancer? CURRENT GENETICS
Artículo2019 Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models Revista Española de Enfermedades Digestivas
Resumen congreso2019 Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2019 Transcriptomic and epigenetic characterization of a NAFLD murine model JOURNAL OF HEPATOLOGY
Resumen congreso2018 Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target. HEPATOLOGY
Artículo2018 High levels of histones promote whole-genome-duplications and trigger a Swe1(WEE1)-dependent phosphorylation of Cdc213(CDK1) eLife
Artículo2017 Coordination of Cell Cycle Progression and Mitotic Spindle Assembly Involves Histone H3 Lysine 4 Methylation by Set1/COMPASS GENETICS
Revisión2017 Regulation of Replication Fork Advance and Stability by Nucleosome Assembly GENES
Artículo2013 Balanced Production of Ribosome Components Is Required for Proper G(1)/S Transition in Saccharomyces cerevisiae JOURNAL OF BIOLOGICAL CHEMISTRY
Artículo2010 FACT Prevents the Accumulation of Free Histones Evicted from Transcribed Chromatin and a Subsequent Cell Cycle Delay in G1 PLOS GENETICS
Revisión2008 Systems for applied gene control in Saccharomyces cerevisiae BIOTECHNOLOGY LETTERS
Artículo2007 An improved system for estradiol-dependent regulation of gene expression in yeast MICROBIAL CELL FACTORIES
Este investigador no ha dirigido/tutorizado tesis

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
13/01/2009 31/12/2013 Investigador/a Síntesis de Ribosomas, Cáncer y Enfermedades Hereditarias. Papel de las Proteínas Ribosómicas y Factores de Ensamblaje de Ribosomas como Posibles Reguladores de la Proliferación Celular (P08-CVI-03508) Junta de Andalucía - Consejería de Innovación, Ciencia y Empresas (Autonómico)
31/01/2008 31/12/2012 Investigador/a Regulación Transcripcional de los Genes Implicados en la Síntesis de Ribosomas: Relación con la Sensibilidad a Drogas Inmunosupresoras e Influencia del Proceso de Ensamblaje de Ribosomas (P07-CVI-02623) Junta de Andalucía - Consejería de Innovación, Ciencia y Empresas (Autonómico)
01/10/2007 04/10/2010 Contratado Análisis genético y genómico de la elongación transcripcional en levaduras (BFU2007-67575-C03-02) Ministerio de Educación y Ciencia (Nacional)
13/01/2009 31/12/2013 Contratado Síntesis de Ribosomas, Cáncer y Enfermedades Hereditarias. Papel de las Proteínas Ribosómicas y Factores de Ensamblaje de Ribosomas como Posibles Reguladores de la Proliferación Celular (P08-CVI-03508) Junta de Andalucía - Consejería de Innovación, Ciencia y Empresas (Autonómico)

Ayudas

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
24/04/2011 22/07/2011 Responsable Estancia en el Instabilité du Genome et Carcinogenesis, Marsella (Francia) (PP2010-05-122) Universidad de Sevilla (Local)
El investigador no tiene ningún resultado de investigación asociado